DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer

Phase 3

Terminated

Conditions: Oropharyngeal Neoplasms

Interventions: Radiation: Intensity-modulated radiation therapy (IMRT)
Drug: Cisplatin

First Posted Date: 2012-09-18

Last Posted Date: 2020-11-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT01687413

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States

Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Phase 2

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions: Drug: decitabine

First Posted Date: 2012-09-18

Last Posted Date: 2018-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 114

Registration Number: NCT01687400

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Dietary Nitrate for Heart Failure

Phase 1

Completed

Conditions: Heart Failure
Hypertension, Pulmonary

Interventions: Dietary Supplement: placebo
Dietary Supplement: Beetroot Juice (BRJ)

First Posted Date: 2012-09-10

Last Posted Date: 2024-12-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT01682356

Locations: 🇺🇸
Indiana University Purdue University Indianapolis, Indianapolis, Indiana, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies

Phase 1

Completed

Conditions: Adenocarcinoma
Pancreatic Neoplasms

Interventions: Drug: MLN8237
Drug: nab-Paclitaxel

First Posted Date: 2012-09-03

Last Posted Date: 2018-01-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT01677559

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Neratinib
Procedure: Tumor biopsy
Drug: Fulvestrant
Drug: Trastuzumab
Procedure: Research blood sample

First Posted Date: 2012-08-22

Last Posted Date: 2022-04-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT01670877

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇺🇸
University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸
University of Miami Hospital and Clinics, Miami, Florida, United States

and more 14 locations

Study to Find the Dose of Rapidly Administered Ketamine for Brief Painful Procedures in Children

Not Applicable

Completed

Conditions: Fracture
Abscess

Interventions: Drug: Ketamine

First Posted Date: 2012-08-21

Last Posted Date: 2019-04-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 111

Registration Number: NCT01669642

Locations: 🇺🇸
St Louis Children's hospital, Washington university, Saint Louis, Missouri, United States

Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)

Phase 2

Withdrawn

Conditions: Carcinoma, Hepatocellular

Interventions: Procedure: radiofrequency ablation
Procedure: laparoscopy

First Posted Date: 2012-08-21

Last Posted Date: 2014-07-16

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01669668

Efavirenz and Ritonavir on Human Brain P-Glycoprotein

Phase 1

Completed

Conditions: Drug Effects

Interventions: Drug: [11C] desmethyl-loperamide
Other: Control - no pretreatment
Drug: Oral ritonavir
Drug: Oral efavirenz

First Posted Date: 2012-08-17

Last Posted Date: 2020-01-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 13

Registration Number: NCT01668147

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Phase 1

Completed

Conditions: Carcinoma, Hepatocellular
Intrahepatic Cholangiocarcinoma

Interventions: Radiation: Stereotactic radiation

First Posted Date: 2012-08-17

Last Posted Date: 2017-02-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 28

Registration Number: NCT01668134

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors

Phase 1

Completed

Conditions: Wilms Tumor
Osteosarcoma
Neuroectodermal Tumors, Primitive
Sarcoma, Ewing
Rhabdomyosarcoma
Retinoblastoma
Glioma

Interventions: Drug: Metronomic Cyclophosphamide
Drug: Thalidomide

First Posted Date: 2012-08-09

Last Posted Date: 2024-01-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT01661400

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy